Drug Shortage Report for AURO-RIZATRIPTAN
| Report ID | 57278 |
| Drug Identification Number | 02441144 |
| Brand name | AURO-RIZATRIPTAN |
| Common or Proper name | Rizatriptan |
| Company Name | AURO PHARMA INC |
| Market Status | DORMANT |
| Active Ingredient(s) | RIZATRIPTAN |
| Strength(s) | 10MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 1x6 & 2x6 |
| ATC code | N02CC |
| ATC description | ANTIMIGRAINE PREPARATIONS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2018-08-01 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2019-03-06 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
| Company contact information | Balaji Srinivasan |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2019-03-06 | French | Compare |
| v4 | 2019-03-06 | English | Compare |
| v3 | 2018-08-02 | English | Compare |
| v2 | 2018-08-01 | French | Compare |
| v1 | 2018-08-01 | English | Compare |
Showing 1 to 5 of 5